In contrast to AI-driven drug discovery companies like Xaira, Recursion, or DeepMind spinout Isomorphic Labs, which focus on ...

Yves Ubelmann declined to digitize Notre Dame. Months later, it burned. Now, with Microsoft’s backing, his startup Iconem is building a photorealistic “digital twin” of ...

For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and ...